Skip to main content
Clinical Trials/TCTR20181204005
TCTR20181204005
Not yet recruiting
Phase 2

Effectiveness of oral glucose solution for the treatment of neonatal hypoglycemia, a randomized, placebo-controlled trial

the Siriraj Research Development Fund (Managed by Routine to Research: R2R).0 sites400 target enrollmentDecember 4, 2018

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
postnatal hypoglycemia in late preterm and term infants
Sponsor
the Siriraj Research Development Fund (Managed by Routine to Research: R2R).
Enrollment
400
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 4, 2018
End Date
December 4, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
the Siriraj Research Development Fund (Managed by Routine to Research: R2R).

Eligibility Criteria

Inclusion Criteria

  • 1\. At least 34\-week's GA
  • 2\. At least 1 risk factor of postnatal hypoglycemia (preterm, maternal diabetes, SGA, LGA, birthweight less than 2500g or more than 4000g)
  • 3\. Asymtomatic hypoglycemia
  • 4\. Age less than 48 hours
  • 5\. No contraindication of oral feedings
  • 6\. Parental written consent

Exclusion Criteria

  • 1\. Blood glucose less than 25 mg/dL
  • 2\. IV fluid is indicated from other reasons
  • 3\. Major anomalies

Outcomes

Primary Outcomes

Not specified

Similar Trials